von Willebrand factor and endothelial damage in essential hypertension.

PubWeight™: 1.63‹?› | Rank: Top 4%

🔗 View Article (PMID 8510081)

Published in J Hum Hypertens on April 01, 1993

Authors

A D Blann1, T Naqvi, M Waite, C N McCollum

Author Affiliations

1: Department of Surgery, University Hospital of South Manchester, Didsbury, UK.

Articles citing this

Soluble cell adhesion molecules and von Willebrand factor in children with Kawasaki disease. Clin Exp Immunol (1995) 1.12

von Willebrand factor and its relevance to cardiovascular disorders. Br Heart J (1995) 0.91

Haemostatic markers are associated with measures of vascular disease in adults with hypertension. J Hum Hypertens (2009) 0.82

Hypertensive stretch regulates endothelial exocytosis of Weibel-Palade bodies through VEGF receptor 2 signaling pathways. Cell Res (2013) 0.81

The association between metabolic syndrome and vascular endothelial dysfunction in adolescents. Exp Ther Med (2013) 0.81

Plasma Levels of Nitrites/Nitrates in Patients with Chronic Atrial Fibrillation are Increased after Electrical Restoration of Sinus Rhythm. J Interv Card Electrophysiol (2002) 0.76

Moderate Dietary Supplementation with Omega-3 Fatty Acids Does Not Impact Plasma Von Willebrand Factor Profile in Mildly Hypertensive Subjects. Biomed Res Int (2015) 0.75

The association between endothelial dysfunction and hypertensive retinopathy in essential hypertension. Med Sci Monit (2014) 0.75

Von Willebrand factor and endothelial damage in essential hypertension. J Hum Hypertens (1995) 0.75

Gene silencing of endothelial von Willebrand Factor attenuates angiotensin II-induced endothelin-1 expression in porcine aortic endothelial cells. Sci Rep (2016) 0.75

Current and Emerging Options for the Management of Inherited von Willebrand Disease. Drugs (2017) 0.75

Association of von Willebrand factor blood levels with exercise hypertension. Eur J Appl Physiol (2014) 0.75

Articles by these authors

Sustained compression and healing of chronic venous ulcers. BMJ (1988) 4.30

Pressure sores. BMJ (1994) 4.04

Community clinics for leg ulcers and impact on healing. BMJ (1992) 3.28

Mannheim carotid intima-media thickness and plaque consensus (2004-2006-2011). An update on behalf of the advisory board of the 3rd, 4th and 5th watching the risk symposia, at the 13th, 15th and 20th European Stroke Conferences, Mannheim, Germany, 2004, Brussels, Belgium, 2006, and Hamburg, Germany, 2011. Cerebrovasc Dis (2012) 3.11

Dynamics of microglial activation: a confocal time-lapse analysis in hippocampal slices. Glia (2001) 2.39

Consultant psychiatrists and abortion. Psychol Med (1974) 2.38

Consultant surgeons and vasectomy. Br Med J (1973) 2.35

General practitioners and birth control advice in 1970-71. Br J Prev Soc Med (1972) 2.24

Evaluation of the HemoCue for measuring intra-operative haemoglobin concentrations: a comparison with the Coulter Max-M. Anaesthesia (1998) 1.80

Ultrasound measurement of aortic diameter in a national screening programme. Eur J Vasc Endovasc Surg (2011) 1.68

Screening for abdominal aortic aneurysm: a computer assisted cost-utility analysis. Eur J Vasc Endovasc Surg (1996) 1.61

Influence of smoking and plasma factors on patency of femoropopliteal vein grafts. BMJ (1989) 1.60

Controlled trial of occlusive dressings in healing chronic venous ulcers. Br J Surg (1987) 1.57

1-O-Alkyl-sn-glyceryl-3-phosphorylcholines: a novel class of neutrophil stimulants. Am J Pathol (1981) 1.56

Does 111indium-platelet deposition predict patency in prosthetic arterial grafts? Br J Surg (1983) 1.55

Relationship between plasma markers of endothelial cell integrity and the Framingham cardiovascular disease risk-factor scores in apparently healthy individuals. Blood Coagul Fibrinolysis (2002) 1.50

Systemic responses in patients with intermittent claudication after treadmill exercise. Br J Surg (1994) 1.48

Early carotid surgery in acute stroke: a multicentre randomised pilot study. Cerebrovasc Dis (2004) 1.43

What are the risk factors for renal failure following open elective abdominal aortic aneurysm repair? Eur J Vasc Endovasc Surg (2011) 1.41

Calcium alginate as haemostatic swabs in hip fracture surgery. J R Coll Surg Edinb (1997) 1.39

Evidence of protein kinase C involvement in phorbol diester-stimulated arachidonic acid release and prostaglandin synthesis. J Biol Chem (1987) 1.39

Delayed carotid surgery: what are the causes in the north west of England? Eur J Vasc Endovasc Surg (2012) 1.38

A novel mechanism of diglyceride formation. 12-O-tetradecanoylphorbol-13-acetate stimulates the cyclic breakdown and resynthesis of phosphatidylcholine. J Biol Chem (1986) 1.36

Studies on the mechanism of fatty acid synthesis. 13. The role of beta-hydroxy acids in the synthesis of palmitate and cis vaccenate by the Escherichia coli enzyme system. J Biol Chem (1966) 1.35

Hydrolysis of phospholipids and glycerides by rat-liver preparations. Biochim Biophys Acta (1967) 1.34

Cerebral injury during cardiopulmonary bypass: emboli impair memory. J Thorac Cardiovasc Surg (2001) 1.31

Disintegration of phosphatidylcholine liposomes in plasma as a result of interaction with high-density lipoproteins. Biochim Biophys Acta (1978) 1.24

Expression of nitric oxide synthase isoforms and arginase in normal human skin and chronic venous leg ulcers. J Pathol (2000) 1.17

Factors associated with healing leg ulceration with high compression. Age Ageing (1995) 1.15

Effect of early blood transfusion on gastrointestinal haemorrhage. Br J Surg (1986) 1.14

Absence of the membrane marker enzyme 5'-nucleotidase in human polymorphonuclear leukocytes. Biochem Med (1976) 1.14

Partial purification and characterization of the phospholipase A 2 from rat liver mitochondria. Biochemistry (1971) 1.11

Lysosomal phospholipase A 1 and A 2 of normal and bacillus calmette guerin-induced alveolar macrophages. J Cell Biol (1973) 1.10

Some properties of phospholipases of alveolar macrophages. Biochim Biophys Acta (1973) 1.10

Carotid disease in acute stroke. Age Ageing (1998) 1.09

Cerebral oximetry in patients undergoing carotid endarterectomy under regional anesthesia. Stroke (1996) 1.08

Ventricular entry during resection of malignant gliomas: effect on intracranial cerebrospinal fluid tumor dissemination. J Neurosurg (1994) 1.07

Requirement for Ca2+ signaling in the mechanism of thrombin-induced increase in endothelial permeability. Am J Physiol Lung Cell Mol Physiol (2001) 1.06

Differentiation of phospholipases A in mitochondria and lysosomes of rat liver. J Lipid Res (1969) 1.06

Prophylaxis for venous thromboembolism during treatment for cancer: questionnaire survey. BMJ (2003) 1.06

G protein-coupled receptor kinase-5 regulates thrombin-activated signaling in endothelial cells. Proc Natl Acad Sci U S A (2000) 1.05

Adverse influence of cigarette smoking on the endothelium. Thromb Haemost (1993) 1.04

Venous disease is associated with an impaired range of ankle movement. Eur J Vasc Endovasc Surg (2003) 1.04

Phagocytosis-induced release of arachidonic acid from human neutrophils. Biochem Biophys Res Commun (1979) 1.04

Confocal imaging of microglial cell dynamics in hippocampal slice cultures. Methods (1999) 1.03

Source of arachidonic acid for prostaglandin synthesis in Madin-Darby canine kidney cells. J Biol Chem (1981) 1.02

Phospholipid hydrolysis by phospholipase A 1 and A 2 in plasma membranes and microsomes of rat liver. Biochim Biophys Acta (1973) 1.02

Sequential changes in histologic pattern and extracellular matrix deposition during the healing of chronic venous ulcers. Am J Pathol (1992) 1.02

Approaches to the study of mammalian cellular phospholipases. J Lipid Res (1985) 1.02

Particulate contaminants of intravenous medications and infusions. J Pharm Pharmacol (1987) 1.01

Venous ulcer fibroblasts compared with normal fibroblasts show differences in collagen but not fibronectin production under both normal and hypoxic conditions. J Invest Dermatol (1996) 1.01

Evaluating the cost and efficacy of leg ulcer care provided in two large UK health authorities. J Wound Care (2002) 1.01

Utilization of neutral glycerides and phosphatidylethanolamine by the phospholipase A-1 of the plasma membranes of rat liver. J Biol Chem (1973) 1.01

Phospholipase A activity of lysosomes of rat myocardial tissue. Biochemistry (1972) 1.00

von Willebrand factor, endothelial cell damage and atherosclerosis. Eur J Vasc Surg (1994) 1.00

The influence of acute smoking on leucocytes, platelets and the endothelium. Atherosclerosis (1998) 0.99

Identification of phospholipase A 1 and A 2 in the soluble fraction of rat liver lysosomes. Biochemistry (1971) 0.99

Synergistic effects of tumor necrosis factor-alpha and thrombin in increasing endothelial permeability. Am J Physiol Lung Cell Mol Physiol (2001) 0.98

Early changes in the haemostatic and procoagulant systems after chemotherapy for breast cancer. Br J Cancer (2008) 0.98

Final inline filtration for intravenous infusions: a prospective hospital study. Br J Surg (1983) 0.97

Prevalence of venous disease: a community study in west London. Eur J Surg (1992) 0.97

Pilot study of carotid surgery for acute stroke. Br J Surg (1997) 0.96

Lipoprotein lipase domain function. J Biol Chem (1994) 0.96

Monitoring wound healing by odour. J Wound Care (1997) 0.96

Soluble P-selectin in atherosclerosis: a comparison with endothelial cell and platelet markers. Thromb Haemost (1997) 0.95

Antithrombotic therapy for vascular prosthesis: an experimental model testing platelet inhibitory drugs. Surgery (1980) 0.95

Circulating endothelial cell/leukocyte adhesion molecules in atherosclerosis. Thromb Haemost (1994) 0.95

Leg ulcer odour detection identifies beta-haemolytic streptococcal infection. J Wound Care (1995) 0.95

Carotid endarterectomy improves cognitive function in patients with exhausted cerebrovascular reserve. Eur J Vasc Endovasc Surg (2003) 0.94

The contribution of the external carotid artery to cerebral perfusion in carotid disease. J Vasc Surg (2000) 0.93

Phosphatidylinositol hydrolysis by phospholipase A2 and C activities in human peripheral blood neutrophils. J Leukoc Biol (1992) 0.92

Superiority of the combination of blood and agitated saline for routine contrast enhancement. J Am Soc Echocardiogr (1999) 0.92

Effect of phagocytosis and ionophores on release and metabolism of arachidonic acid from human neutrophils. Lipids (1981) 0.92

A questionnaire to assess risk factors, quality of life, and use of health resources in patients with venous disease. Eur J Surg (1992) 0.92

Phospholipid synthesis in human embryo fibroblasts infected with herpes simplex virus type 2. Lipids (1981) 0.92

Myocardial phospholipase A of microsomal and mitochondrial fractions. Biochim Biophys Acta (1971) 0.92

Circulating endothelial cell/leucocyte adhesion molecules in ischaemic heart disease. Br J Haematol (1996) 0.91

General practitioners and contraception in 1970-71. J R Coll Gen Pract (1972) 0.91

Cerebral embolisation during modern cardiopulmonary bypass. Eur J Cardiothorac Surg (2001) 0.91

Neutrophil responses to platelet-activating factor. Inflammation (1981) 0.90

Femoropopliteal bypass grafts--an isotope technique allowing in vivo comparison of thrombogenicity. Br J Surg (1982) 0.90

Mechanism of arachidonic acid release in human polymorphonuclear leukocytes. Biochim Biophys Acta (1983) 0.90

Arterial graft maturation: the duration of thrombotic activity in Dacron aortobifemoral grafts measured by platelet and fibrinogen kinetics. Br J Surg (1981) 0.89

Preoperative cardiopulmonary exercise testing and risk of early mortality following abdominal aortic aneurysm repair. Br J Surg (2012) 0.89

Rheological properties and function of blood cells in stored bank blood and salvaged blood. Br J Haematol (1998) 0.89

Light-reflective cerebral oximetry and jugular bulb venous oxygen saturation during carotid endarterectomy. Br J Surg (1994) 0.88

Increased soluble P-selectin following myocardial infarction: a new marker for the progression of atherosclerosis. Blood Coagul Fibrinolysis (1997) 0.88

National risk prediction model for elective abdominal aortic aneurysm repair. Br J Surg (2013) 0.88

Should heparin be reversed after carotid endarterectomy? A randomised prospective trial. Eur J Vasc Endovasc Surg (1997) 0.87

Increased levels of soluble tumor necrosis factor receptors in atherosclerosis: no clear relationship with levels of tumor necrosis factor. Inflammation (1998) 0.87

Studies on the substrate specificity of the phospholipase A1 of the plasma membrane of rat liver. J Biol Chem (1974) 0.87

Prevention of venous thromboembolism in surgical patients with breast cancer. Br J Surg (2007) 0.87

Iliac artery aneurysm simulating nerve root compression. J R Coll Surg Edinb (1983) 0.87

The influence of smoking and of oral and transdermal nicotine on blood pressure, and haematology and coagulation indices. Thromb Haemost (1997) 0.87

Circulating endothelial cell markers in peripheral vascular disease: relationship to the location and extent of atherosclerotic disease. Eur J Clin Invest (1997) 0.87

Relation between calcium requirement, substrate charge, and rabbit polymorphonuclear leukocyte phospholipase A2 activity. Biochemistry (1978) 0.87

Mitochondrial phospholipase A2 activity and mitochondrial aging. Biochemistry (1978) 0.87

Expression of cyclooxygenase isoforms in normal human skin and chronic venous ulcers. J Pathol (2001) 0.86

Solubilization by heparin of the phospholipase A1 from the plasma membranes of rat liver. J Biol Chem (1973) 0.86